MolecuLightDX: Revolutionizing Wound Care with Fluorescence Imaging
A new MolecuLight video demonstrates the MolecuLightDX, an FDA-cleared device using fluorescence imaging to detect bacteria in wounds, enhancing clinical outcomes. It supports real-time assessment and targeted treatment for wound care professionals.
Key Highlights:
- Bacterial Detection: Visualizes bacteria at or below the skin surface, aiding precise wound assessment.
- FDA-Cleared: Clinically validated for reliability in detecting bacterial presence in various wound types.
- Clinical Applications: Guides debridement and treatment, reducing infection risks and improving healing.
- User-Friendly: Portable, non-invasive, and integrates seamlessly into clinical workflows.
The MolecuLightDX empowers clinicians to optimize wound management with cutting-edge technology.
Learn more about the product on the MolecuLightDX product sheet.
Keywords:
Fluorescence imaging,
MolecuLightDX,
Wound assessment,
Bacterial detection,
Wound care technology